These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12644257)

  • 1. Glucose-lowering effect of beta-phenylpyruvate in neonatal mice: a possible mechanism for phenylketonuria-related neurodegenerative changes.
    Gazit V; Ben-Abraham R; Rudin M; Katz Y
    Brain Res Dev Brain Res; 2003 Mar; 141(1-2):137-40. PubMed ID: 12644257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Phenylpyruvate induces long-term neurobehavioral damage and brain necrosis in neonatal mice.
    Gazit V; Ben-Abraham R; Pick CG; Katz Y
    Behav Brain Res; 2003 Jul; 143(1):1-5. PubMed ID: 12842290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicity.
    Gazit V; Ben-Abraham R; Coleman R; Weizman A; Katz Y
    Amino Acids; 2004 Mar; 26(2):163-8. PubMed ID: 15042446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-phenylpyruvate and glucose uptake in isolated mouse soleus muscle and cultured C2C12 muscle cells.
    Ben-Abraham R; Gazit V; Vofsi O; Ben-Shlomo I; Reznick AZ; Katz Y
    J Cell Biochem; 2003 Dec; 90(5):957-63. PubMed ID: 14624455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylpyruvate, fetal damage, and maternal phenylketonuria syndrome.
    Dorland L; Poll-The BT; Duran M; Smeitink JA; Berger R
    Lancet; 1993 May; 341(8856):1351-2. PubMed ID: 8098485
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of 3-phenylpyruvate-induced insulin release. Secretory, ionic and oxidative aspects.
    Sener A; Welsh M; Lebrun P; Garcia-Morales P; Saceda M; Malaisse-Lagae F; Herchuelz A; Valverde I; Hellerström C; Malaisse WJ
    Biochem J; 1983 Mar; 210(3):913-9. PubMed ID: 6347184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal age influences hypoglycemia-induced neuronal injury in the rat brain.
    Ennis K; Tran PV; Seaquist ER; Rao R
    Brain Res; 2008 Aug; 1224():119-26. PubMed ID: 18582442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine.
    Loo YH; Scotto J; Wisniewski HM
    Adv Exp Med Biol; 1978; 100():453-69. PubMed ID: 151497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylketonuria: metabolic alterations induced by phenylalanine and phenylpyruvate.
    Patel MS; Arinze IJ
    Am J Clin Nutr; 1975 Feb; 28(2):183-8. PubMed ID: 234671
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible biochemical model for phenylketonuria.
    Bowden JA; McArthur CL
    Nature; 1972 Jan; 235(5335):230. PubMed ID: 4551128
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of L-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex.
    Glazer RI; Weber G
    Brain Res; 1971 Oct; 33(2):439-50. PubMed ID: 5167448
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation.
    Paranjape SA; Briski KP
    Neuroscience; 2005; 130(4):957-70. PubMed ID: 15652993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction.
    Abdelmalik PA; Shannon P; Yiu A; Liang P; Adamchik Y; Weisspapir M; Samoilova M; Burnham WM; Carlen PL
    Neurobiol Dis; 2007 Jun; 26(3):646-60. PubMed ID: 17459717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory.
    Loepke AW; Istaphanous GK; McAuliffe JJ; Miles L; Hughes EA; McCann JC; Harlow KE; Kurth CD; Williams MT; Vorhees CV; Danzer SC
    Anesth Analg; 2009 Jan; 108(1):90-104. PubMed ID: 19095836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral lipid metabolism in experimental hyperphenylalaninaemia: incorporation of 14C-labelled glucose into total lipids.
    Shah SN; Peterson NA; McKean CM
    J Neurochem; 1970 Feb; 17(2):279-84. PubMed ID: 5531260
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyruvate metabolism by homogenates of human brain: effects of phenylpyruvate and implications for the etiology of the mental retardation in phenylketonuria.
    Patel MS; Grover WD; Auerbach VH
    J Neurochem; 1973 Feb; 20(2):289-96. PubMed ID: 4698280
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance of endogenous phenylpyruvate in phenylketonurics.
    Zelnícek E; Podhradská O
    Clin Chim Acta; 1969 Jul; 25(1):179-80. PubMed ID: 5797121
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia.
    Sarkissian CN; Scriver CR; Mamer OA
    Anal Biochem; 2000 May; 280(2):242-9. PubMed ID: 10790306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of phenylpyruvate on pyruvate metabolism in rat brain.
    Patel MS
    Biochem J; 1972 Jul; 128(3):677-84. PubMed ID: 4634834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of phenylpyruvate and hyperphenylalaninemia on incorporation of (6- 3 H)glucose into macromolecules of slices of rat cerebral cortex.
    Glazer RI; Weber G
    J Neurochem; 1971 Dec; 18(12):2371-82. PubMed ID: 5167512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.